Related Experiment Video
Updated: May 27, 2026

A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
Gastrointestinal hormones: uroguanylin-a new gut-derived weapon against obesity?
Abstract:
A recent report has identified uroguanylin as an endocrine signal that exerts a physiological role in energy homeostasis, adding another factor to the gut–brain axis. From a clinical point of view, several observations highlight the uroguanylin–guanylyl cyclase C pathway as a potential therapeutic target for the development of antiobesity drugs.
Insights
Uroguanylin is an endocrine signal regulating energy homeostasis and the gut-brain axis. This discovery highlights the uroguanylin-guanylyl cyclase C pathway as a promising target for novel antiobesity drug development.
Area of Science:
- Endocrinology
- Neuroscience
- Metabolic Research
Background:
- Uroguanylin identified as a key endocrine signal involved in regulating energy homeostasis.
- The gut-brain axis is increasingly recognized for its role in metabolic regulation.
- Existing research points to the uroguanylin-guanylyl cyclase C pathway's physiological significance.
Discussion:
- Uroguanylin's role extends beyond gastrointestinal function to systemic energy balance.
- The gut-brain axis integrates peripheral signals to modulate central appetite and metabolism.
- The interplay between uroguanylin and guanylyl cyclase C offers a novel mechanistic understanding.
Key Insights:
- Uroguanylin acts as an endocrine mediator influencing energy homeostasis.
- The gut-brain axis is a critical communication network for metabolic control.
- The uroguanylin-guanylyl cyclase C pathway is a significant physiological system.
Outlook:
- Potential for developing targeted antiobesity therapeutics.
- Further research into uroguanylin signaling pathways is warranted.
- Clinical implications for metabolic disease management are substantial.
More Related Videos
07:00Mechanisms Underlying Gut Hormone Secretion Using the Isolated Perfused Rat Small Intestine
Published on: February 26, 2019
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Related Concept Videos
Hormonal Regulation
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Regulation of Food Intake
Regulation of the Digestive System
The effectors in this regulation system are glands and smooth muscles. Activation of these...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Hormones Secreted by the Stomach
Each of these hormones secreted by different enteroendocrine cells plays a unique role in digestion. Here are a few examples: